Dr. O’Connor on Real-World Results With Regorafenib in mCRC OncLive 1:28 5 years ago 219 Скачать Далее
REGINA: regorafenib, nivolumab and short-course radiotherapy for rectal cancer VJOncology 1:53 3 years ago 172 Скачать Далее
Survival Benefit Confirmed in Real-Life Analysis of Second-Line Regorafenib in HCC Targeted Oncology 1:09 4 years ago 297 Скачать Далее
Metastatic colorectal cancer: trifluridine/tiripacil or regorafenib? VJOncology 2:52 6 years ago 1 266 Скачать Далее
The rationale for combining regorafenib with IO to treat patients with refractory MSS-CRC VJOncology 1:23 2 years ago 104 Скачать Далее
Colorectal Cancer: Regorafenib Patient Selection and Dosing OncLive 5:32 7 years ago 231 Скачать Далее
Dr. Lenz on Choosing Between Regorafenib and TAS-102 in CRC OncLive 1:12 3 years ago 297 Скачать Далее
Prior RT may potentially enhance treatment of MSS-CRC with regorafenib and pembrolizumab VJOncology 6:56 2 years ago 155 Скачать Далее
Dr. Udit Verma on Managing Regorafenib Side Effects in CRC OncLive 1:38 7 years ago 181 Скачать Далее
Dr. George Demetri Explains the Side Effects Associated With Regorafenib OncLive 1:21 12 years ago 900 Скачать Далее